Veterinary Sciences (Jan 2023)

Subunit Vaccine Targeting Phosphate ABC Transporter ATP-Binding Protein, PstB, Provides Cross-Protection against <i>Streptococcus suis</i> Serotype 2, 7, and 9 in Mice

  • Zujie Yan,
  • Xiaohui Yao,
  • Ruyi Pan,
  • Junjie Zhang,
  • Xiaochun Ma,
  • Nihua Dong,
  • Jianchao Wei,
  • Ke Liu,
  • Yafeng Qiu,
  • Katie Sealey,
  • Hester Nichols,
  • Michael A. Jarvis,
  • Mathew Upton,
  • Xiangdong Li,
  • Zhiyong Ma,
  • Juxiang Liu,
  • Beibei Li

DOI
https://doi.org/10.3390/vetsci10010048
Journal volume & issue
Vol. 10, no. 1
p. 48

Abstract

Read online

Streptococcus suis is a significant pathogen in pigs and a newly emerging zoonotic agent in humans. The presence of multiple serotypes and strains with diversified sequence types in pig herds highlights the need for the identification of broadly cross-reactive universal vaccine antigen targets, capable of providing cross-protection against S. suis infection. Subunit vaccines based on the conserved proteins shared between different S. suis serotypes are potential candidates for such a universally protective vaccine. In the present study, phosphate ABC transporter ATP-binding protein PstB (PstB), an immunogenic protein of the S. suis bacterium, was expressed and purified, and then subjected to cross-protection evaluation in mice. The PstB protein showed nearly 100% amino acid similarity across a panel of 31 S. suis isolates representing different serotypes, which were collected from different countries. A recombinant PstB (rPstB) protein (S. suis serotype 2) was recognized by rabbit sera specific to this serotype, and induced high levels of IFN-γ and IL-4 in mice immunized with the recombinant protein. These cytokines are considered important for protection against S. suis infection. Immunization of mice with rPstB resulted in an 87.5% protection against challenge with S. suis serotype 2 and 9 strains, suggesting a high level of cross-protection for S. suis serotypes 2 and 9. A lower protection rate (62.5%) was observed in mice challenged with the S. suis serotype 7 strain. These data demonstrate that PstB is a promising target antigen for development as a component of a universal subunit vaccine against multiple S. suis serotypes.

Keywords